Advertisements



Denali Therapeutics: Key Catalysts Coming Up For This Neurodegenerative Disease Pioneer

Denali Therapeutics: Key Catalysts Coming Up For This Neurodegenerative Disease Pioneer.....»»

Category: topSource: seekingalphaJun 12th, 2019

Denali Therapeutics announces ODD, Rare Pediatric Disease Designation for DNL310

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2019

Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Opened Enrollment of PROPEL Phase 1/2 Trial of PR001 to Treat Parkinson's Disease Patients with G.....»»

Category: earningsSource: benzingaNov 12th, 2019

Carlisle Companies Has Catalysts Coming But Is Currently Fairly Valued

Carlisle Companies Has Catalysts Coming But Is Currently Fairly Valued.....»»

Category: topSource: seekingalphaNov 11th, 2019

CytomX Therapeutics downgraded on lack of short-term catalysts at Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 11th, 2019

Netflix Sees More Free Cash in the Future

The pioneer in online movie streaming services is undaunted with up and coming competitorsRelated Stocks: NFLX,.....»»

Category: blogSource: gurufocusNov 8th, 2019

Denali Therapeutics reports Q3 EPS (48c), consensus (56c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 6th, 2019

With Disney, Apple about to enter, the streaming wars are just beginning

Apple Inc's Apple TV+ and Walt Disney Co's Disney+ will launch competitors to streaming video pioneer Netflix Inc in November. Several others already have hit the market or will debut in the coming months......»»

Category: topSource: reutersOct 30th, 2019

Were Hedge Funds Right About Ditching Denali Therapeutics Inc. (DNLI)?

The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 de.....»»

Category: topSource: insidermonkeyOct 27th, 2019

Achillion Makes Significant Advancement With FDA Designation, Sets Up Big Catalysts In Coming Months

Achillion Makes Significant Advancement With FDA Designation, Sets Up Big Catalysts In Coming Months.....»»

Category: topSource: seekingalphaOct 9th, 2019

PTC Therapeutics STRIDE data shows Translarna slows disease progression

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2019

Denali Therapeutics initiated with a Neutral on valuation at Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 26th, 2019

Aquestive Therapeutics: Finally Looking For Entry Ahead Of Key Catalysts

Aquestive Therapeutics: Finally Looking For Entry Ahead Of Key Catalysts.....»»

Category: topSource: seekingalphaSep 25th, 2019

Denali Therapeutics initiated with a Neutral at Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2019

Mateon Therapeutics granted Rare Pediatric Disease Designation for OT101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2019

Denali Therapeutics started at buy with $35 stock price target at Instinet

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 13th, 2019

Denali Therapeutics initiated with a Buy at Nomura Instinet

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2019

Denali Therapeutics doses first patient in Phase 1b study of DNL151

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2019

$4.3B deal delayed again: Roche extends Spark Therapeutics offer for sixth time

The slow-moving regulatory review process is once again being blamed for the latest delay in Roche’s proposed $4.3 billion acquisition of Philadelphia gene therapy pioneer Spark Therapeutics Inc. Roche said on Monday it is extending the offering per.....»»

Category: topSource: bizjournalsSep 3rd, 2019

Therapeutics startup raises $65M in latest round to fight kidney disease

Chinook Therapeutics is based in Vancouver, B.C., but its CEO lives and works in Seattle — and he's looking to for space in the city to support six to 12 additional employees......»»

Category: topSource: bizjournalsAug 23rd, 2019

Rare disease biotech SpringWorks Therapeutics files for a $115 million IPO

SpringWorks Ther.....»»

Category: futuresSource: nasdaqAug 16th, 2019